WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
Operating Income ScalingExpanding
Percentile Rank71
3Y CAGR+2.2%
5Y CAGR+12.0%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+2.2%/yr
vs +7.0%/yr prior
5Y CAGR
+12.0%/yr
Recent deceleration
Acceleration
-4.8pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$10.54B+26.0%
2024$8.36B+18.4%
2023$7.06B-28.5%
2022$9.87B+85.2%
2021$5.33B-10.9%
2020$5.99B-9.8%
2019$6.64B-11.9%
2018$7.54B-8.4%
2017$8.23B-32.6%
2016$12.22B-